A detailed history of First National Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, First National Corp holds 6,936 shares of ABBV stock, worth $1.31 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
6,936
Previous 7,019 1.18%
Holding current value
$1.31 Million
Previous $1.2 Million 13.8%
% of portfolio
0.3%
Previous 0.29%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$163.84 - $199.33 $13,598 - $16,544
-83 Reduced 1.18%
6,936 $1.37 Million
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $53,712 - $62,723
347 Added 5.2%
7,019 $1.2 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $6,192 - $6,973
45 Added 0.68%
6,672 $1.03 Million
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $7,420 - $9,234
56 Added 0.85%
6,627 $892,000
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $2,952 - $3,386
-22 Reduced 0.33%
6,571 $882,000
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $2,752 - $3,499
20 Added 0.3%
6,593 $1.01 Million
Q1 2022

Apr 26, 2022

SELL
$131.98 - $163.75 $10,822 - $13,427
-82 Reduced 1.23%
6,573 $1.07 Million
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $214 - $271
-2 Reduced 0.03%
6,655 $901,000
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $17,662 - $20,049
166 Added 2.56%
6,657 $718,000
Q2 2021

Jul 30, 2021

BUY
$105.21 - $117.21 $18,727 - $20,863
178 Added 2.82%
6,491 $637,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $1,125 - $1,238
11 Added 0.17%
6,313 $683,000
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $15,212 - $20,538
-189 Reduced 2.91%
6,302 $675,000
Q2 2020

Jul 21, 2020

SELL
$73.37 - $98.18 $733 - $981
-10 Reduced 0.15%
6,491 $637,000
Q1 2020

Apr 16, 2020

BUY
$64.5 - $97.79 $6,450 - $9,779
100 Added 1.56%
6,501 $706,000
Q4 2019

Jan 31, 2020

SELL
$72.13 - $90.25 $30,871 - $38,627
-428 Reduced 6.27%
6,401 $567,000
Q3 2019

Oct 24, 2019

SELL
$62.98 - $75.72 $141,893 - $170,597
-2,253 Reduced 24.81%
6,829 $517,000
Q2 2019

Jul 30, 2019

SELL
$65.7 - $83.98 $86,395 - $110,433
-1,315 Reduced 12.65%
9,082 $660,000
Q1 2019

Jun 12, 2019

SELL
$77.14 - $90.79 $191,692 - $225,613
-2,485 Reduced 19.29%
10,397 $22,000
Q4 2018

Jun 12, 2019

BUY
$77.85 - $96.01 $1 Million - $1.24 Million
12,882 New
12,882 $1.19 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First National Corp Portfolio

Follow First National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

News

Stay updated on First National Corp with notifications on news.